Human C3 glomerulopathy provides unique insights into complement factor H-related protein function

V Michael Holers1

  • 1Department of Medicine, Division of Rheumatology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA. michael.holers@ucdenver.edu

Insights

A gene duplication in complement factor H–related 1 (CFHR1) creates a larger FHR1 protein. This aberrant form impairs complement regulation by competing with factor H (FH) binding, offering insights into inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Complement factor H-related proteins (FHRs) are implicated in inflammatory and autoimmune diseases.
  • The precise function and regulation of FHR proteins, particularly FHR1, remain incompletely understood.
  • Genetic variations in FHR genes are associated with various human pathologies.

Purpose of the Study:

  • To investigate the functional consequences of a duplication mutation in the CFHR1 gene.
  • To elucidate the mechanism by which mutant FHR1 affects complement regulation.
  • To provide insights into the role of FHR proteins in human diseases.

Main Methods:

  • In vitro studies using mutant and normal variants of FHR1.
  • Analysis of protein homodimerization and hetero-oligomerization with FHR2 and FHR5.
  • Assessment of FHR1's competitive binding to surfaces and its impact on complement activation.

Main Results:

  • A duplication in CFHR1 leads to the production of an abnormally larger FHR1 protein.
  • Mutant FHR1 forms more avid homodimers and hetero-oligomers with FHR2 and FHR5.
  • These aberrant FHR1 complexes effectively compete with factor H (FH) for surface binding, inhibiting complement regulation.

Conclusions:

  • The study reveals an unexpected mechanism of FHR1 action involving oligomerization.
  • Aberrant FHR1 variants can disrupt local complement activation, contributing to disease pathogenesis.
  • These findings enhance understanding of FHR protein function and their link to inflammatory and autoimmune conditions.